Albumin-bound docetaxel
Sponsors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions
Advanced Solid Tumors
Phase 1
Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel
NCT04471675
Start: 2020-12-02End: 2023-12-15Target: 208Updated: 2022-01-31
A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors
NCT05114915
Start: 2022-01-07End: 2023-10-31Target: 144Updated: 2022-01-31